Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017714HBVENSG00000122194.20protein_codingPLGNoNo5340P00747
Q5TEH5
TVIS10015036HBVENSG00000122194.20protein_codingPLGNoNo5340P00747
Q5TEH5
TVIS10030720HBVENSG00000122194.20protein_codingPLGNoNo5340P00747
Q5TEH5
TVIS10035479HBVENSG00000122194.20protein_codingPLGNoNo5340P00747
Q5TEH5
TVIS10018975HBVENSG00000122194.20protein_codingPLGNoNo5340P00747
Q5TEH5
TVIS10049265HBVENSG00000122194.20protein_codingPLGNoNo5340P00747
Q5TEH5
TVIS20002315HPVENSG00000122194.20protein_codingPLGNoNo5340P00747
Q5TEH5
TVIS44045260HTLV-1ENSG00000122194.20protein_codingPLGNoNo5340P00747
Q5TEH5
TVIS44045289HTLV-1ENSG00000122194.20protein_codingPLGNoNo5340P00747
Q5TEH5
TCGA Plot Options
Drug Information
GenePLG
DrugBank IDDB00015
Drug NameReteplase
Target IDBE0000211
UniProt IDP00747
Regulation Typeactivator
PubMed IDs17963464; 18673235; 19436656; 11752352
CitationsHilleman DE, Tsikouris JP, Seals AA, Marmur JD: Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Pharmacotherapy. 2007 Nov;27(11):1558-70.@@Longstaff C, Williams S, Thelwell C: Fibrin binding and the regulation of plasminogen activators during thrombolytic therapy. Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):212-23.@@Melandri G, Vagnarelli F, Calabrese D, Semprini F, Nanni S, Branzi A: Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction. Vasc Health Risk Manag. 2009;5(1):249-56. Epub 2009 Apr 8.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
PathwaysReteplase Action Pathway
PharmGKBPA164743728
ChEMBLCHEMBL2107885